ALEXANDRIA, Va., Aug. 3 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'TOZRILBI' in its latest official gazette. The trademark application with the serial number 99830101 was filed on May 18, 2026.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Antibodies for medical purposes;...
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): AstraZeneca AB Astraallén Södertälje SE Sweden SE-15185 64 AK...